Market Overview

RMTI LOSS NOTICE: Rosen Law Firm Reminds Rockwell Medical, Inc. Investors of Important Deadline in Case - RMTI

Share:

Rosen Law Firm, a global investor rights law firm, reminds purchasers of
the securities of Rockwell Medical, Inc. (NASDAQ:RMTI) between March
16, 2018 and June 26, 2018, inclusive (the "Class Period") of the
important September 25, 2018 lead plaintiff deadline in the class
action. The lawsuit seeks to recover damages for Rockwell investors
under the federal securities laws.

To join the Rockwell class action, go to http://www.rosenlegal.com/cases-1347.html
or call Phillip Kim, Esq. or Zachary Halper, Esq. toll-free at
866-767-3653 or email pkim@rosenlegal.com
or zhalper@rosenlegal.com
for information on the class action.

NO CLASS HAS YET BEEN CERTIFIED IN THE ABOVE ACTION. UNTIL A CLASS IS
CERTIFIED, YOU ARE NOT REPRESENTED BY COUNSEL UNLESS YOU RETAIN ONE. YOU
MAY RETAIN COUNSEL OF YOUR CHOICE. YOU MAY ALSO REMAIN AN ABSENT CLASS
MEMBER AND DO NOTHING AT THIS POINT. AN INVESTOR'S ABILITY TO SHARE IN
ANY POTENTIAL FUTURE RECOVERY IS NOT DEPENDENT UPON SERVING AS LEAD
PLAINTIFF.

According to the lawsuit, defendants during the Class Period made
materially false and/or misleading statements and/or failed to disclose
that: (1) Rockwell was aware that the Centers for Medicare and Medicaid
Services would not pursue Rockwell's proposal for separate reimbursement
for Triferic; (2) the estimated reserves in Rockwell's Form 10-Q for the
quarter ended March 31, 2018 were misstated; (3) there was a material
weakness in Rockwell's internal controls over financial reporting; (4)
consequently, Rockwell's internal controls over financial reporting were
ineffective during the Class Period; (5) defendant Robert L. Chioini,
Rockwell's former Chief Executive Officer, withheld material information
regarding Triferic from Rockwell's auditor, corporate counsel and five
independent directors of Rockwell's Board; and (6) as a result,
defendants' statements about Rockwell's business, operations and
prospects were materially false and misleading and/or lacked reasonable
bases at all relevant times. When the true details entered the market,
the lawsuit claims that investors suffered damages.

A class action lawsuit has already been filed. If you wish to serve as
lead plaintiff, you must move the Court no later than September 25,
2018. A lead plaintiff is a representative party acting on behalf of
other class members in directing the litigation. If you wish to join the
litigation, go to http://www.rosenlegal.com/cases-1347.html
to join the class action. You may also contact Phillip Kim or
Zachary Halper of Rosen Law Firm toll free at 866-767-3653 or via email
at pkim@rosenlegal.com or zhalper@rosenlegal.com.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm
or on Twitter: https://twitter.com/rosen_firm.

Rosen Law Firm represents investors throughout the globe, concentrating
its practice in securities class actions and shareholder derivative
litigation. Rosen Law Firm was Ranked No. 1 by ISS Securities Class
Action Services for number of securities class action settlements in
2017. The firm has been ranked in the top 3 each year since 2013.
Attorney Advertising. Prior results do not guarantee a similar outcome.

-------------------------------

Contact Information:

Laurence Rosen, Esq.
Phillip Kim, Esq.
Zachary Halper, Esq.
The
Rosen Law Firm, P.A.
275 Madison Avenue, 34th Floor
New
York, NY 10016
Tel: (212) 686-1060
Toll Free: (866) 767-3653
Fax:
(212) 202-3827
lrosen@rosenlegal.com
pkim@rosenlegal.com
zhalper@rosenlegal.com
www.rosenlegal.com

View Comments and Join the Discussion!